arrow
N

Niall Conlon

St James's Hospital
H指数:30
被引数:5,600

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Penicillin allergy de-labelling in the critical care unit: Simulations to design an intravenous drug provocation test that mirrors the plasma profile of an enteral challenge

重症监护病房中的青霉素过敏去标签化:模拟设计一种静脉药物激发试验,该试验能模拟经肠挑战的血浆轮廓

2025-12-010
OAAI
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
2025-11-150
OAAI
Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential

数字评估的长期COVID症状学与淋巴细胞线粒体功能障碍和改变的免疫潜力相关

2025-11-010
PRE
Applying Human Factors/Ergonomics to support change in healthcare - An innovative co-designed approach to conducting antibiotic allergy de-labelling in the intensive care unit

将人因工程/工效学应用于支持医疗保健领域的变革——一种创新性共同设计方法,用于在重症监护室开展抗生素过敏标签移除工作

2025-10-090
OAAI
Clinical performance of the fully automated Lumipulse plasma p-tau217 assay in mild cognitive impairment and mild dementia

全自动Lumipulse血浆p-tau217测定在轻度认知障碍和轻度痴呆中的临床性能

2025-02-140
OAAI
Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitis
2024-12-010
OAAI
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
2023-11-018
PRE
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon (vol 14, 3513, 2023)

富马酸二甲酯和衣康酸4-辛酯是通过抑制I型干扰素抑制巨噬细胞组织因子的抗凝剂 (第14卷,3513,2023)

2023-07-200
OAAI
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon

富马酸二甲酯和衣康酸4-辛酯是通过抑制I型干扰素抑制巨噬细胞组织因子的抗凝剂

2023-06-1421
OAAI
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19
2023-03-3014
OAAI